- Oops!Something went wrong.Please try again later.
CEO & Chief Scientific Officer of Amphastar Pharmaceuticals Inc (30-Year Financial, Insider Trades) Jack Y. Zhang (insider trades) sold 300,000 shares of AMPH on 09/11/2019 at an average price of $20.82 a share. The total sale was $6.2 million.
Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings. Amphastar Pharmaceuticals Inc has a market cap of $1.02 billion; its shares were traded at around $21.62 with a P/E ratio of 20.21 and P/S ratio of 3.29. GuruFocus has detected 1 severe warning sign with Amphastar Pharmaceuticals Inc. .
CEO Recent Trades:
CEO & Chief Scientific Officer, 10% Owner Jack Y. Zhang sold 300,000 shares of AMPH stock on 09/11/2019 at the average price of $20.82. The price of the stock has increased by 3.84% since.
CFO Recent Trades:
CFO, SVP & Treasurer William J Peters sold 4,942 shares of AMPH stock on 08/15/2019 at the average price of $21. The price of the stock has increased by 2.95% since.
Directors and Officers Recent Trades:
SVP Corp Admin Center Yakob Liawatidewi sold 3,910 shares of AMPH stock on 09/06/2019 at the average price of $21.65. The price of the stock has decreased by 0.14% since.
Director Richard K Prins sold 7,500 shares of AMPH stock on 08/26/2019 at the average price of $22.59. The price of the stock has decreased by 4.29% since.
For the complete insider trading history of AMPH, click here
.This article first appeared on GuruFocus.